Deferasirox induced liver injury in haemochromatosis.
نویسندگان
چکیده
Durg-induced liver injury is a common side-effect of many medicines. It is particularly problem when the original condition under treatment is already causing liver damage. This report describes the hepatotoxicity induced by Deferasirox in a patient with haemochromatosis with a discussion of possible pathogenetic mechanism.
منابع مشابه
Pseudogout, chondrocalcinosis and the early recognition of haemochromatosis.
Idiopathic haemochromatosis is a disorder which has a well-known association with chondrocalcinosis. We report arthritis associated with chondrocalcinosis as the first clinical manifestation of underlying haemochromatosis in two otherwise asymptomatic male patients. In one patient, pyrophosphate arthropathy presented with acute pseudogout. Better appreciation of this presentation will result in...
متن کاملDeferasirox associated with liver failure and death in a sickle cell anemia patient homozygous for the −1774delG polymorphism in the Abcc2 gene
This manuscript describes the case of a patient with sickle cell anemia who died of fulminant hepatitis after therapy with the iron chelator Deferasirox. The patient was homozygous for the -1774delG polymorphism in the Abcc2 gene, which raises the concern about the use of hepatotoxic drugs in this specific context.
متن کاملDeferasirox-induced iron depletion promotes BclxL downregulation and death of proximal tubular cells
Iron deficiency has been associated with kidney injury. Deferasirox is an oral iron chelator used to treat blood transfusion-related iron overload. Nephrotoxicity is the most serious and common adverse effect of deferasirox and may present as an acute or chronic kidney disease. However, scarce data are available on the molecular mechanisms of nephrotoxicity. We explored the therapeutic modulati...
متن کاملSerum increase and liver overexpression of carbohydrate 19.9 antigen in patients with genetic haemochromatosis.
CA 19.9 antigen is mainly secreted by biliary and pancreatic duct cells. Its metabolism could be modified in genetic haemochromatosis by iron accumulation within these cells. Therefore, CA 19.9 was assayed in the serum samples of 84 patients with genetic haemochromatosis before and after iron depletion and immunolocalised in the liver of 24 untreated genetic haemochromatosis cases. The study sh...
متن کاملJuvenile hemochromatosis: HAMP mutation and severe iron overload treated with phlebotomies and deferasirox
Juvenile hemochromatosis (JH) is a rare condition classified as an autosomal recessive disorder that leads to severe iron absorption. JH usually affects people under the age of 30 and presents symptoms such as chronic liver damage, hypogonadotropic hypogonadism, cardiac diseases and endocrine dysfunctions. The present case reports a 29-year-old Brazilian woman with JH condition due to HAMP muta...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Journal of the College of Physicians and Surgeons--Pakistan : JCPSP
دوره 21 11 شماره
صفحات -
تاریخ انتشار 2010